| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.015 | 0.7 |